SC
EPZM

Slow Capital’s Epizyme, Inc EPZM Stock Holding History

Slow Capital’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-44,879
Closed -$487K – 179
2020
Q4 		$487K Buy
44,879
+5,274
+13% +$65.1K 0.12% 143
2020
Q3 		$472K Buy
39,605
+16,855
+74% +$226K 0.13% 140
2020
Q2 		$365K Buy
22,750
+1,260
+6% +$22K 0.11% 142
2020
Q1 		$333K Sell
21,490
-6,707
-24% -$144K 0.13% 140
2019
Q4 		$694K Buy
28,197
+8,118
+40% +$121K 0.21% 132
2019
Q3 		$207K Sell
20,079
-1,344
-6% -$17K 0.07% 162
2019
Q2 		$269K Sell
21,423
-4,136
-16% -$53.2K 0.11% 158
2019
Q1 		$317K Buy
+25,559
New +$286K 0.13% 154

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Slow Capital's EPZM Position: Q1 2021 in Review

Slow Capital sold out of Epizyme, Inc (EPZM) in Q1 2021, closing a stake of 44,879 shares — an estimated $487K sold.

Slow Capital first reported a position in EPZM in Q1 2019 and held it in 8 quarters. The position peaked at $694K in Q4 2019. 138 funds tracked by Wall St. Rank hold EPZM as of Q1 2021.

  • Slow Capital reported no remaining Epizyme, Inc position as of Q1 2021 after selling out during the quarter.
  • Slow Capital sold 44,879 Epizyme, Inc shares in Q1 2021, an estimated $487K.
  • Slow Capital first reported a position in Epizyme, Inc in Q1 2019 and held it in 8 quarters.
  • Slow Capital's Epizyme, Inc position peaked at $694K in Q4 2019.
  • 138 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2021.

Based on Slow Capital's 13F filing for Q1 2021, filed 5 May 2021.